Interv Akut Kardiol. 2009;8(5):251-254

Patient selection and investigation prior to transcatheter aortic valve implantation

Martin Mates1, Jan Kováč2
1 Kardiocentrum dospělých, oddělení invazivní kardiologie interní kliniky 2. LF UK a FN Motol, Praha
2 Kardiologická klinika Glenfieldské všeobecné nemocnice, Velká Británie

Transcatheter aortic valve implantation has become a new method available in management of patients with severe aortic stenosis

contraindicated for conventional cardiac surgery. Patient selection and assessment of specific morphological criteria obtained by

echocardiography and angiography required for certain type of prosthesis are essential parts of pre-operative assessment and are

critical for successful intervention.

Keywords: aortic stenosis, transcatheter aortic valve implantation, echocardiography.

Published: November 20, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mates M, Kováč J. Patient selection and investigation prior to transcatheter aortic valve implantation. Interv Akut Kardiol. 2009;8(5):251-254.
Download citation

References

  1. Bonow RO, Carabello BA, Kanu C, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography Interventions, Society of Thoracic Surgeons. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-e231. Go to original source... Go to PubMed...
  2. Vahanian A, Baumgartner H, Bax J, et al. Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268.
  3. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on valvular disease. Eur Heart J 2003; 24: 1231-1243. Go to original source... Go to PubMed...
  4. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-3008. Go to original source... Go to PubMed...
  5. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal 2008; 29(11): 1463-1470. Go to original source... Go to PubMed...
  6. Želízko M, Janek B, Netuka I, et al. Perkutánní implantace aortální chlopně u nemocné s těsnou aortální stenózou. Interv Akut Kardiol 2009; 8(1): 43-45.
  7. Šťásek J, Vojáček J, Bis J, et al. První zkušenost s perkutánní transfemorální implantací chlopně Edwards SAPIEN(TM) u nemocných s aortální stenózou. Interv Akut Kardiol 2009; 8(1): 46-49.
  8. Vojáček J. První katetrizační implantace aortálních chlopní v České republice. Interv Akut Kardiol 2009; 8: 43-46.
  9. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval) Eurointervention 2008; 4: 242-249. Go to original source... Go to PubMed...
  10. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second and current third generation self expanding CoreValve prosthesis J Am Coll Cardiol 2007; 50: 69-76. Go to original source... Go to PubMed...
  11. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with percutaneous heart valve J Am Coll Cardiol 2006; 47: 1214-1223. Go to original source... Go to PubMed...
  12. Webb JG, Pasupati S, Humphries K, et al. Percutaneous aortic valve replacement in selected high risk patients with aortic stenosis Circulation 2007; 116: 755-776. Go to original source... Go to PubMed...
  13. Jilaihawi H, Chin D, Vasa-Nicotera M, et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J. 2009; 157(5): 860-866. Go to original source... Go to PubMed...
  14. Dewey TM, Brown D, Ryan W, et al. Reliability of risk algorithms in predicting early and late operative outcomes in high risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008; 135: 180-187. Go to original source... Go to PubMed...
  15. Moss R, Ivens E, Pasupati S, et al. Role of Echocardiography in Percutaneous Aortic Valve Implantation. J Am Coll Cardiol Img 2008; 1; 15-24. Go to original source... Go to PubMed...
  16. Derek C. Echocardiography for transcatheter aortic valve implantation European Journal of Echocardiography 2009; 10: 21-29. Go to original source... Go to PubMed...
  17. Tops L, Wood D, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography: implications for transcatheter aortic valve replacement. J Am Coll Cardiol Img 2008; 1: 321-330. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.